These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 10736251)

  • 1. Placental synthesis of oestriol in Down's syndrome pregnancies.
    Newby D; Aitken DA; Howatson AG; Connor JM
    Placenta; 2000; 21(2-3):263-7. PubMed ID: 10736251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second trimester amniotic fluid oestriol, dehydroepiandrosterone sulphate, and human chorionic gonadotrophin levels in Down's syndrome.
    Cuckle HS; Wald NJ; Densem JW; Canick J; Abell KB
    Br J Obstet Gynaecol; 1991 Nov; 98(11):1160-2. PubMed ID: 1836960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amniotic fluid levels of CA 19.9 and CA 15.3 in normal and Down's syndrome pregnancies.
    Noci I; Borri P; Biagiotti R; Cariati E; Branconi F; Torricelli F; Cappelli G; D'Agata A
    J Perinat Med; 1995; 23(3):237-41. PubMed ID: 8568617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies.
    Newby D; Aitken DA; Crossley JA; Howatson AG; Macri JN; Connor JM
    Prenat Diagn; 1997 Oct; 17(10):941-51. PubMed ID: 9358574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental and maternal serum inhibin-A and activin-A levels in Down's syndrome pregnancies.
    Dalgliesh GL; Aitken DA; Lyall F; Howatson AG; Connor JM
    Placenta; 2001; 22(2-3):227-34. PubMed ID: 11170828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat-stable and immunoreactive placental alkaline phosphatase in maternal serum from Down's syndrome and trisomy 18 pregnancies.
    Aitken DA; Syvertsen BS; Crossley JA; Berry E; Connor JM
    Prenat Diagn; 1996 Nov; 16(11):1051-4. PubMed ID: 8953641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
    Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.
    Canick JA; Knight GJ; Palomaki GE; Haddow JE; Cuckle HS; Wald NJ
    Br J Obstet Gynaecol; 1988 Apr; 95(4):330-3. PubMed ID: 2968116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum markers for Down's syndrome pregnancies.
    Chew S; Anandakumar C; Ratnam SS
    Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies.
    Marcos J; Craig WY; Palomaki GE; Kloza EM; Haddow JE; Roberson M; Bradley LA; Shackleton CH
    Prenat Diagn; 2009 Aug; 29(8):771-80. PubMed ID: 19418464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
    Wald NJ; Cuckle HS; Densem JW; Stone RB
    Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of human placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome.
    Sifakis S; Papadopoulou E; Konstantinidou A; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2009 Apr; 19(2):121-5. PubMed ID: 18793862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of trisomy 21 in amniotic fluid.
    Spencer K; Muller F; Aitken DA
    Prenat Diagn; 1997 Jan; 17(1):31-7. PubMed ID: 9021826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down's syndrome screening marker levels following assisted reproduction.
    Barkai G; Goldman B; Ries L; Chaki R; Dor J; Cuckle H
    Prenat Diagn; 1996 Dec; 16(12):1111-4. PubMed ID: 8994246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.
    Crossley JA; Aitken DA; Connor JM
    Prenat Diagn; 1993 Apr; 13(4):271-80. PubMed ID: 7685092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
    Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL
    J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome.
    Kim SY; Kim SK; Lee JS; Kim IK; Lee K
    Yonsei Med J; 2000 Apr; 41(2):226-9. PubMed ID: 10817024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.